These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22210352)

  • 1. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent.
    Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H
    Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
    Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
    Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
    Zhang H; Wu J; Yuan J; Li H; Zhang Y; Wu W; Chen W; Wang C; Meng S; Chen S; Huo M; He Y; Zhang C
    J Exp Clin Cancer Res; 2021 Aug; 40(1):260. PubMed ID: 34412665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen.
    Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H
    Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model.
    Ye SF; Li J; Ji SM; Zeng HH; Lu W
    Acta Pharmacol Sin; 2017 Feb; 38(2):223-232. PubMed ID: 27917873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells.
    Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H
    Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1.
    Zhang X; Lu J; Ren X; Du Y; Zheng Y; Ioannou PV; Holmgren A
    Free Radic Biol Med; 2015 Dec; 89():192-200. PubMed ID: 26169724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance.
    Engelman R; Ziv T; Arnér ESJ; Benhar M
    Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
    Du Y; Zhang H; Lu J; Holmgren A
    J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of thioredoxin reductase 1 in dysplastic transformation of human breast epithelial cells triggered by chronic oxidative stress.
    Dong C; Zhang L; Sun R; Liu J; Yin H; Li X; Zheng X; Zeng H
    Sci Rep; 2016 Nov; 6():36860. PubMed ID: 27845427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.
    Jovanović M; Zhukovsky D; Podolski-Renić A; Domračeva I; Žalubovskis R; Senćanski M; Glišić S; Sharoyko V; Tennikova T; Dar'in D; Pešić M; Krasavin M
    Eur J Med Chem; 2019 Nov; 181():111580. PubMed ID: 31400708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.
    Ye SF; Yang Y; Wu L; Ma WW; Zeng HH
    J Zhejiang Univ Sci B; 2017 May; 18(5):373-382. PubMed ID: 28471109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioredoxin reductase 1 and NADPH directly protect protein tyrosine phosphatase 1B from inactivation during H
    Dagnell M; Pace PE; Cheng Q; Frijhoff J; Östman A; Arnér ESJ; Hampton MB; Winterbourn CC
    J Biol Chem; 2017 Sep; 292(35):14371-14380. PubMed ID: 28684416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
    Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
    Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
    Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
    Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice].
    Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH
    Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
    Anestål K; Arnér ES
    J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions.
    Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L
    Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Details in the catalytic mechanism of mammalian thioredoxin reductase 1 revealed using point mutations and juglone-coupled enzyme activities.
    Xu J; Cheng Q; Arnér ES
    Free Radic Biol Med; 2016 May; 94():110-20. PubMed ID: 26898501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin.
    Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L
    Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.